Literature DB >> 7674214

Prospective hematologic and clinicopathologic study of asymptomatic cats with naturally acquired feline immunodeficiency virus infection.

G H Shelton1, M L Linenberger, M T Persik, J L Abkowitz.   

Abstract

Prospective studies were performed over a 28- to 77-month period (median, 66 months) on 5 cats with naturally acquired feline immunodeficiency virus (FIV) infection in an attempt to correlate hematologic and clinicopathologic changes with the emergence of clinical disease. On presentation, all cats were asymptomatic; free of opportunistic infections; and had normal complete blood counts, bone marrow morphologies, marrow progenitor frequencies, and progenitor in vitro growth characteristics. During study, 2 cats remained healthy, 2 cats showed mild clinical signs, and 1 cat developed a malignant neoplasm (ie, bronchiolar-alveolar adenocarcinoma). Although persistent hematologic abnormalities were not observed, intermittent peripheral leukopenias were common. In 3 of 5 FIV-seropositive cats, lymphopenia (< 1,500 lymphs/microL; normal reference range, 1,500 to 7,000 lymphs/microL) was a frequent finding and the absolute lymphocyte counts had a tendency to progressively decline. One of the other 2 cats had consistently low to low-normal absolute neutrophil counts (1,300 to 4,800 segs/microL; mean, 2,730 segs/microL; normal reference range, 2,500 to 12,500 segs/microL), and the remaining cat had consistently normal leukograms, except for a transient period (ie, 11 months) of benign lymphocytosis (7,200 to 13,430 lymphs/microL) early in the study. Periodic examinations of bone marrow aspirates revealed normal to slightly depressed myeloid-to-erythroid ratios with normal cellular morphology and maturation. Bone marrow abnormalities observed late in the study included mild dysmorphic changes (ie, megaloblastic features) in 2 cats, and a significant decrease (60% of controls, P < .001) in the frequencies of burst-forming units erythroid (BFU-E) in marrow cultures of FIV-seropositive cats compared with uninfected control cats.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1995        PMID: 7674214      PMCID: PMC7166774          DOI: 10.1111/j.1939-1676.1995.tb03286.x

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  23 in total

Review 1.  Hematologic abnormalities in cats seropositive for feline immunodeficiency virus.

Authors:  G H Shelton; M L Linenberger; J L Abkowitz
Journal:  J Am Vet Med Assoc       Date:  1991-11-15       Impact factor: 1.936

2.  Clinical, hematologic, and survival data from cats infected with feline immunodeficiency virus: 42 cases (1983-1988).

Authors:  E J Fleming; D L McCaw; J A Smith; G M Buening; C Johnson
Journal:  J Am Vet Med Assoc       Date:  1991-10-01       Impact factor: 1.936

3.  Early loss of circulating hemopoietic progenitors in HIV-1-infected subjects.

Authors:  G P Bagnara; G Zauli; M Giovannini; M C Re; G Furlini; M La Placa
Journal:  Exp Hematol       Date:  1990-06       Impact factor: 3.084

4.  Acquired immune dysfunction in cats with experimentally induced feline immunodeficiency virus infection: comparison of short-term and long-term infections.

Authors:  J E Barlough; C D Ackley; J W George; N Levy; R Acevedo; P F Moore; B A Rideout; M D Cooper; N C Pedersen
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1991

5.  Epidemiologic and clinical aspects of feline immunodeficiency virus infection in cats from the continental United States and Canada and possible mode of transmission.

Authors:  J K Yamamoto; H Hansen; E W Ho; T Y Morishita; T Okuda; T R Sawa; R M Nakamura; N C Pedersen
Journal:  J Am Vet Med Assoc       Date:  1989-01-15       Impact factor: 1.936

6.  In vivo lymphocyte tropism of feline immunodeficiency virus.

Authors:  R V English; C M Johnson; D H Gebhard; M B Tompkins
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

7.  An early defect in primary and secondary T cell responses in asymptomatic cats during acute feline immunodeficiency virus (FIV) infection.

Authors:  S A Bishop; N A Williams; T J Gruffydd-Jones; D A Harbour; C R Stokes
Journal:  Clin Exp Immunol       Date:  1992-12       Impact factor: 4.330

8.  Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome.

Authors:  H C Lane; H Masur; L C Edgar; G Whalen; A H Rook; A S Fauci
Journal:  N Engl J Med       Date:  1983-08-25       Impact factor: 91.245

9.  Pathogenesis of experimentally induced feline immunodeficiency virus infection in cats.

Authors:  J K Yamamoto; E Sparger; E W Ho; P R Andersen; T P O'Connor; C P Mandell; L Lowenstine; R Munn; N C Pedersen
Journal:  Am J Vet Res       Date:  1988-08       Impact factor: 1.156

10.  Immunologic abnormalities in pathogen-free cats experimentally infected with feline immunodeficiency virus.

Authors:  C D Ackley; J K Yamamoto; N Levy; N C Pedersen; M D Cooper
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

View more
  10 in total

1.  Naturally acquired feline immunodeficiency virus (FIV) infection in cats from western Canada: Prevalence, disease associations, and survival analysis.

Authors:  Madhu Ravi; Gary A Wobeser; Susan M Taylor; Marion L Jackson
Journal:  Can Vet J       Date:  2010-03       Impact factor: 1.008

2.  Parameters of disease progression in long-term experimental feline retrovirus (feline immunodeficiency virus and feline leukemia virus) infections: hematology, clinical chemistry, and lymphocyte subsets.

Authors:  R Hofmann-Lehmann; E Holznagel; P Ossent; H Lutz
Journal:  Clin Diagn Lab Immunol       Date:  1997-01

3.  Assessing the impact of feline immunodeficiency virus and bovine tuberculosis co-infection in African lions.

Authors:  M Maas; D F Keet; V P M G Rutten; J A P Heesterbeek; M Nielen
Journal:  Proc Biol Sci       Date:  2012-08-22       Impact factor: 5.349

Review 4.  HIV-1 and drug abuse comorbidity: Lessons learned from the animal models of NeuroHIV.

Authors:  Susmita Sil; Annadurai Thangaraj; Ernest T Chivero; Fang Niu; Muthukumar Kannan; Ke Liao; Peter S Silverstein; Palsamy Periyasamy; Shilpa Buch
Journal:  Neurosci Lett       Date:  2021-03-29       Impact factor: 3.197

Review 5.  Feline blood transfusions: A pinker shade of pale.

Authors:  Dominic Barfield; Sophie Adamantos
Journal:  J Feline Med Surg       Date:  2011-01       Impact factor: 2.015

6.  Immunopathologic Effects of Prednisolone and Cyclosporine A on Feline Immunodeficiency Virus Replication and Persistence.

Authors:  Craig Miller; Jordan Powers; Esther Musselman; Ryan Mackie; John Elder; Sue VandeWoude
Journal:  Viruses       Date:  2019-08-30       Impact factor: 5.048

7.  Feline immunodeficiency virus (FIV) infection in domestic pet cats in Australia and New Zealand: Guidelines for diagnosis, prevention and management.

Authors:  M E Westman; S J Coggins; M van Dorsselaer; J M Norris; R A Squires; M Thompson; R Malik
Journal:  Aust Vet J       Date:  2022-05-16       Impact factor: 1.343

8.  Plasma electrophoretogram in feline immunodeficiency virus (FIV) and/or feline leukaemia virus (FeLV) infections.

Authors:  G Miró; A Doménech; E Escolar; V M Collado; G Tejerizo; A De Las Heras; E Gómez-Lucía
Journal:  J Vet Med A Physiol Pathol Clin Med       Date:  2007-05

Review 9.  Haematological disorders associated with feline retrovirus infections.

Authors:  M L Linenberger; J L Abkowitz
Journal:  Baillieres Clin Haematol       Date:  1995-03

10.  Feline immunodeficiency virus (FIV) infection leads to increased incidence of feline odontoclastic resorptive lesions (FORL).

Authors:  R Hofmann-Lehmann; M Berger; B Sigrist; P Schawalder; H Lutz
Journal:  Vet Immunol Immunopathol       Date:  1998-10-23       Impact factor: 2.046

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.